# G-13b-vuln-ADV: Red-Team Vulnerability Analysis Score

## L0 Executive Summary

**Score:** 0.868/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Internal Consistency (0.78)
**One-line assessment:** The report is substantively strong with genuine adversarial chain analysis but has three concrete defects -- a broken RED-005/AS-5 source attribution, a CVSS AV:N field that should be AV:L for an insider-only attack (RED-001), and a partially unverifiable deduplication count -- that prevent it from reaching the 0.95 threshold at C4.

## Verdict: REVISE
## Weighted Composite: 0.868
## Iteration: 1 of 8

---

## Scoring Context

- **Deliverable:** `projects/PROJ-021-use-case/orchestration/use-case-skills-20260308-001/security/red-team-vulnerabilities.md`
- **Deliverable Type:** Security Analysis (Red-Team Vulnerability Report)
- **Criticality Level:** C4
- **Engagement:** RED-0001 (PROJ-021 Phase 3b, step-11b-vuln)
- **Scoring Strategy:** S-014 (LLM-as-Judge) + all 9 C4 companion strategies
- **Quality Threshold:** 0.95 (user override C-008; standard H-13 threshold is 0.92)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Prior Scope Score:** G-13b-scope-ADV = 0.952 PASS
- **Scored:** 2026-03-09

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.868 |
| **Threshold** | 0.95 (C-008 override) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | Yes -- all 10 C4 strategies applied |
| **Critical Findings** | 0 (no automatic REVISE triggers from strategy execution beyond score) |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.88 | 0.176 | All 9 AS analyzed, all required sections present; deduplication count (23) partially unverifiable from matrix alone |
| Internal Consistency | 0.20 | 0.78 | 0.156 | RED-005/AS-5 contradiction, CVSS AV:N vs insider-only scope, escalated count discrepancy (1 vs 2 in L0 vs matrix) |
| Methodological Rigor | 0.20 | 0.88 | 0.176 | PTES+NIST SP 800-115, full CVSS vectors, ATT&CK for LLMs; one CVSS AV field error reduces score |
| Evidence Quality | 0.15 | 0.90 | 0.135 | Specific field paths, file references, adversarial payloads, verbatim citations; confirmatory assertions without inline evidence |
| Actionability | 0.15 | 0.93 | 0.140 | REC-001 through REC-008 with exact YAML snippets, file targets, bash_allowlist regexes, P0/P1/P2 ordering |
| Traceability | 0.10 | 0.85 | 0.085 | RED-*-to-SEC-*-to-CWE-to-ATT&CK chain present; AS-5 to RED-005 trace broken; deduplication count claim partially unverifiable |
| **TOTAL** | **1.00** | | **0.868** | |

---

## Detailed Dimension Analysis

### Completeness (0.88/1.00)

**Evidence:**

All nine attack surfaces (AS-1 through AS-9) have dedicated sections with feasibility assessments. The document structure includes all required components: L0 Executive Summary, L1 Technical Detail (per-AS sections), L2 Strategic Implications, Findings Table (RED-001 through RED-008), Deduplication Matrix (RED-* vs SEC-*), Risk Heat Map (9-surface x 4-skill matrix), Recommendations (P0/P1/P2/P3 with REC-001 through REC-008), and S-010 Self-Review Checklist (15 items). Eight new RED-* findings are documented. The deduplication baseline of 23 prior findings is claimed and the S-010 checklist self-certifies coverage.

**Gaps:**

1. The deduplication count of "20 confirmed" in the L0 severity table is difficult to independently verify from the Deduplication Matrix alone. The matrix's explicitly listed confirmed-as-accurately-scoped table shows 7 specific findings (SEC-003, SEC-004, SEC-006, SEC-007 from step-9; SEC-007, SEC-008 from step-10; SEC-CD-002, SEC-CD-003, SEC-CD-006 from step-11). The remaining 13 of the 20 claimed "confirmed" are accounted for only implicitly through RED-* linkage, not enumerated individually. A reviewer cannot independently count to 23 without additional cross-referencing.

2. AS-5 (Template Injection) concludes "No separate RED-* finding created" but the Findings Table then lists RED-005 with "AS-5/AS-8" as source. The AS-5 template injection analysis lacks a clear disposition statement that ties it to its ultimate RED-* assignment.

**Improvement Path:**

Add an explicit enumeration of all 23 prior findings in the Deduplication Matrix (or an appendix) with their disposition (escalated, extended, or confirmed as scoped). Resolve the AS-5 disposition by either creating a RED-* for template injection or explicitly noting that the template injection findings are subsumed into RED-002's scope.

---

### Internal Consistency (0.78/1.00)

**Evidence:**

Three concrete inconsistencies identified across sections:

1. **RED-005/AS-5 contradiction:** AS-5 section (line 239) states: "No separate RED-* finding created; instead, SEC-CD-001 is escalated to HIGH based on this multi-angle analysis." However, the Findings Table (line 476) lists `RED-005 | AS-5/AS-8 | MEDIUM | 6.3 | CWE-22, CWE-78 | Output path traversal + Bash escalation combined attack chain`. The Deduplication Matrix entry for RED-005 covers "path traversal as part of a pipeline attack chain" -- this is the AS-8/path-traversal finding, not the AS-5 template injection. The Finding Table's attribution "AS-5/AS-8" directly contradicts AS-5's stated conclusion.

2. **Escalated count discrepancy:** The L0 severity table shows "Escalated = 1" (one finding upgraded in severity). The Deduplication Matrix shows two findings with "Escalates" as overlap type: RED-004 ("Escalates -- severity upgrade") and RED-005 ("Escalates -- cross-skill chain"). If RED-005 is an escalation, the L0 count should be 2, not 1. If RED-005 is not an escalation (per the "Extends" language sometimes used elsewhere), the Deduplication Matrix should not use "Escalates" for it. This creates ambiguity in the total finding counts.

3. **CVSS AV:N for insider-only attack (RED-001):** The CVSS 3.1 vector for RED-001 is stated as `AV:N/AC:H/PR:L/UI:R/S:C/C:L/I:H/A:N = 7.1`. However, the mitigating factors (line 301-304) explicitly state: "UC artifacts are internally authored within the Jerry framework (not from external untrusted users)" and the attack requires a local insider who crafts a UC artifact. AV:N (Network) is defined as "The vulnerable component is bound to the network stack and the set of possible attackers extends beyond the other options listed above." An insider-only attack requiring local authorship of a UC artifact fits AV:L (Local) or at most AV:P (Physical), not AV:N. With AV:L, the CVSS score would reduce to approximately 6.2 (Medium), changing the severity classification from HIGH 7.1.

**Gaps:**

The above three inconsistencies are all verifiable from the document text alone and are not interpretation-dependent. The CVSS AV field issue is a scoring methodology concern in a security report where CVSS accuracy is a core deliverable standard.

**Improvement Path:**

1. Resolve the RED-005/AS-5 contradiction: either retitle the AS-5 section's conclusion to reference RED-005 explicitly, or remove AS-5/AS-8 attribution from the Findings Table and replace with AS-8 only.
2. Correct the L0 Escalated count from 1 to 2 (or correct the Deduplication Matrix to use "Extends" for RED-005 consistently).
3. Revise RED-001 CVSS vector: change AV:N to AV:L. Recompute the score (approximately 6.2 Medium vs 7.1 High), which would require re-evaluating whether RED-001 retains HIGH severity on adjusted vector or is reframed with qualitative HIGH justification independent of the numeric CVSS score.

---

### Methodological Rigor (0.88/1.00)

**Evidence:**

The methodology is explicitly stated (PTES Vulnerability Analysis Phase + NIST SP 800-115 Chapter 5) and operationalized consistently. Each attack surface section follows the same structure: attack surface description, feasibility assessment, red-team analysis with specific vectors, mitigating factors, CVSS 3.1 vector (with all 8 fields), CWE, and ATT&CK for LLMs technique reference. The adversarial chain analysis for RED-001 (five-step kill chain at lines 258-286) is methodologically sound -- it demonstrates how individually rated MEDIUM findings combine into a HIGH cross-skill finding. The PROTOTYPE label bypass analysis (RED-004, three distinct paths at lines 382-400) correctly identifies generation-time, validation-time, and post-generation-time as separate lifecycle points for a single security control. The confidence disclosure (0.91 with specific limitation: "behavioral guardrail bypass scenarios are theoretical and cannot be fully validated without live agent execution") follows P-022.

**Gaps:**

The CVSS AV:N field for RED-001 is a methodological error that conflicts with the stated attack conditions. CVSS 3.1 methodology requires the AV field to reflect the most constrained access path needed by the attacker. An insider-only attack on an internal tool is definitionally not AV:N. This undermines the methodological claim of "CVSS 3.1 vectors applied consistently."

**Improvement Path:**

Revise RED-001 CVSS vector and add a note explaining how the HIGH severity classification is maintained even with AV:L (if the intent is to maintain HIGH, the qualitative analysis supports it, but the numeric vector must be accurate). This requires re-examining whether the CVSS score for other insider-only findings (RED-003, RED-004) also have consistent AV field selection.

---

### Evidence Quality (0.90/1.00)

**Evidence:**

The report demonstrates strong evidence practice throughout. RED-002 (Prompt Injection) enumerates six specific vulnerable field paths (`$.basic_flow[*].action`, `$.extensions[*].condition`, `$.interactions[*].request_description`, etc.) and provides a concrete adversarial payload example in a YAML code block. RED-001 (Pipeline Poisoning) cites specific agent file behavior: "tspec-generator.md: 'Read use case artifacts and validate YAML frontmatter against docs/schemas/use-case-realization-v1.schema.json'" (lines 292-294) -- the verbatim quote from the agent file supports the cross-skill trust inheritance claim. RED-004 cites "cd-validator Step 7" specifically. The Deduplication Matrix cites specific SEC-* finding IDs from prior reviews. ATT&CK for LLMs (ATLAS) technique references (AML.T0051, AML.T0040, AML.T0043) are specific identifiers that can be cross-referenced.

**Gaps:**

Some confirmatory claims ("confirmed by reading all agent .md files" at line 88, "confirmed in uc-author.agent.yaml" at line 90) are assertions without inline evidence. In a report intended to stand alone for security audit purposes, the key structural evidence (e.g., the Tool list declaration confirming Task is absent) should be quoted or cited with line numbers, not asserted. This is a minor quality gap -- the report format does not lend itself to exhaustive quoting -- but it reduces the independently verifiable evidence density for confirmatory claims.

**Improvement Path:**

For the key structural confirmations (P-003 enforcement matrix, Tool list confirmation), add a brief inline evidence snippet or reference the specific governance YAML field that was confirmed, rather than using "confirmed by reading all files" as a single catch-all assertion.

---

### Actionability (0.93/1.00)

**Evidence:**

Recommendations are highly specific. REC-001 names the exact file (`docs/schemas/use-case-realization-v1.schema.json`), provides two implementation options (A: `additionalProperties: false` with enumerated properties; B: root-level allowlist with documentation), and explains the downstream impact (blocks RED-001, RED-003, reduces SEC-002 risk). REC-002 provides the exact `forbidden_actions` entry text for cd-generator.governance.yaml, including the full NPT-009-format string with consequence. REC-004 provides specific regex patterns per agent (`["^uv run jerry validate.*$"]`), covering all six agents individually. REC-005 provides the exact YAML `output_filtering` entry and the exact guardrail text to add to the `<guardrails>` section. The P0/P1/P2/P3 priority ordering with explicit GATE-5b disposition guidance ("Must disposition before gate" vs "Remediation plan required" vs "Document and track") provides actionable triage language for the security review process.

**Gaps:**

REC-006 through REC-008 (P2 hardening) are less specific than P0/P1 recommendations. REC-006 says "Add explicit output format check" without providing the guardrail text. REC-007 says "add negative keywords" without specifying which keywords. These are appropriate for P2 recommendations (hardening, not blocking), but the actionability difference is noted.

**Improvement Path:**

No critical improvement needed for actionability -- the P0/P1 recommendations that block GATE-5b are fully actionable. For completeness, providing draft negative keyword entries for REC-007 would raise this dimension's score to the 0.95+ range.

---

### Traceability (0.85/1.00)

**Evidence:**

Each RED-* finding traces to: an attack surface (AS-N field in AS section headers), a prior finding (SEC-* reference in Deduplication Matrix), a CWE identifier, a CVSS 3.1 vector, and an ATT&CK technique. Recommendations (REC-*) reference their source RED-* findings ("RED-001 / extends SEC-002", "RED-004 Paths 2 and 3", etc.). The Risk Heat Map shows finding-to-attack-surface-to-skill traceability. The S-010 Self-Review Checklist traces each quality assertion to its evidence. The navigation table provides section-level traceability.

**Gaps:**

1. The AS-5 to RED-* traceability is broken: AS-5 terminates with "No separate RED-* finding created; SEC-CD-001 is escalated to HIGH" but the Findings Table lists RED-005 with AS-5/AS-8 attribution, and the Deduplication Matrix for RED-005 covers only path traversal (not template injection). The template injection escalation of SEC-CD-001 has no traceable path from the AS-5 analysis to a specific finding entry.

2. The deduplication count claim (23 prior findings accounted for) cannot be fully verified from the Deduplication Matrix's explicit entries. The trace from the "23 prior findings" baseline to the specific coverage of each of the 23 is incomplete.

**Improvement Path:**

Add a line at the end of AS-5 that explicitly states the disposition: either "Template injection escalation of SEC-CD-001 is covered under RED-002 (Prompt Injection -- same underlying mechanism; see Deduplication Matrix)" or create a separate entry. Add a complete enumeration of all 23 prior findings to the Deduplication Matrix.

---

## Strategy Application Summary

### S-003 Steelman (Applied First per H-16)

The report achieves genuine adversarial value beyond the static reviews. RED-001 (pipeline poisoning) is the clearest example: it correctly identifies that three individually MEDIUM findings combine into a HIGH-severity cross-skill attack chain invisible in per-skill analysis. RED-004's three-bypass-path analysis is methodologically sound and the severity escalation from MEDIUM to HIGH is well-justified by the combined lifecycle coverage (generation, validation, post-generation). The CVSS vector specificity and ATT&CK for LLMs technique references demonstrate domain competence. The actionable recommendations include specific implementation artifacts (exact YAML text, regex patterns) that enable direct implementation without further research. The report is structurally complete against the stated evaluation criteria.

### S-013 Inversion

Inversion analysis revealed that this report avoids all major failure modes of a poor vulnerability analysis (verbatim static finding repetition, missing attack surfaces, CVSS scores without vectors, no deduplication, vague remediation). Inversion at the margin identified three gaps: the AS-5/RED-005 source attribution contradiction, the CVSS AV field inconsistency for RED-001, and the partially unverifiable deduplication count. These are the primary sources of the Internal Consistency and Traceability dimension deductions.

### S-007 Constitutional AI Critique

The report is fully compliant. P-003 verified (no subagents spawned, read-only assessment). P-020 verified (user authority respected throughout; no unilateral changes proposed). P-022 verified (confidence 0.91 disclosed with specific limitation at header level; all findings labeled as theoretical adversarial analysis). The adversarial payload examples are appropriately bounded as theoretical rather than weaponized. No constitutional violations found.

### S-002 Devil's Advocate

Three challenges accepted: (1) RED-001's CVSS AV:N is defensible as a "worst-case" assessment convention, but CVSS 3.1 methodology requires accurate rather than conservative AV field selection -- the challenge stands. (2) RED-004 CVSS I:H for a process bypass is somewhat overstated (prototype-labeled contracts being treated as production is a business integrity issue, not a system integrity issue in the CVSS definition), but the field-level edit scenario does constitute a file modification impacting integrity, so I:H is defensible. (3) The deduplication table format (showing only confirmed-as-scoped entries rather than all 23) is a presentation choice that reduces verifiability but does not represent an actual coverage gap, assuming the analyst read all 23 prior findings.

### S-004 Pre-Mortem Analysis

Risk of over-restriction: RED-001's AV:N framing may cause the security reviewer to treat it as an externally exploitable vulnerability requiring urgent patching, when the actual threat actor is an authenticated internal user. This could lead to over-engineering the `additionalProperties: false` change if reviewers prioritize it as an external attack vector. Mitigation: correcting AV:N to AV:L will recalibrate reviewer expectations. Risk of under-restriction: the AS-5 template injection escalation of SEC-CD-001 to HIGH is not captured in any RED-* finding and does not appear in the Findings Table. A GATE-5b reviewer using only the Findings Table (8 findings) would miss this escalated finding, potentially allowing a HIGH-severity finding to go undispositioned. This is the most significant pre-mortem risk from the report's current state.

### S-010 Self-Refine

The report's internal S-010 checklist (15 items, all PASS) did not catch the RED-005/AS-5 contradiction or the CVSS AV:N inconsistency. The checklist item 4 ("RED-* findings are genuinely new or escalated") would not catch source attribution inconsistencies, only whether findings are substantively new. The checklist item 5 ("CVSS scores applied consistently per CVSS 3.1 methodology") was self-rated PASS but the AV:N error persisted. This indicates the self-review checklist, while valuable, does not substitute for adversarial scoring.

### S-012 FMEA

Failure modes in the report itself (not in the analyzed system):

| FM | Failure Mode | Severity | Occurrence | RPN Impact |
|----|-------------|----------|------------|------------|
| FM-1 | CVSS AV:N for insider-only attack (RED-001) | Medium | Confirmed | Misleads severity assessment |
| FM-2 | AS-5/RED-005 source attribution contradiction | Low-Medium | Confirmed | Breaks traceability for one finding |
| FM-3 | Deduplication count not fully enumerable from matrix | Medium | Confirmed | Reduces verifiability claim |
| FM-4 | AS-5 template injection escalation of SEC-CD-001 not in Findings Table | Medium | Confirmed | HIGH finding invisible in primary findings inventory |
| FM-5 | PROTOTYPE label escalation counted as "Escalated=1" in L0 but RED-005 also "Escalates" | Low | Confirmed | Minor count inconsistency |

FM-4 is the highest-impact failure mode: a HIGH-severity finding (SEC-CD-001 escalated by AS-5) is not in the Findings Table and therefore would not be tracked in GATE-5b disposition.

### S-011 Chain-of-Verification

Verified claims:
- "All 9 attack surfaces analyzed": CONFIRMED (AS-1 through AS-9 each have sections)
- "8 new RED-* findings": CONFIRMED (RED-001 through RED-008 in Findings Table)
- "L0/L1/L2 output levels present": CONFIRMED (sections at lines 29, 78, 425)
- "Navigation table present with anchor links (H-23)": CONFIRMED (lines 14-26)
- "CVSS 3.1 vectors fully specified for all findings": PARTIALLY CONFIRMED (AV:N error in RED-001)
- "3 escalated findings": PARTIALLY CONFIRMED (L0 shows 1 escalated, matrix shows 2 "Escalates" entries -- discrepancy)
- "23 prior findings accounted for": PARTIALLY CONFIRMED (consistent claim but not independently enumerable from matrix alone)
- "Constitutional compliance P-003/P-020/P-022": CONFIRMED (no violations found)

### S-001 Red Team Analysis (of the report itself)

The adversarial payload examples in the report (YAML injection examples at lines 145-151, 186-193) are bounded within markdown code blocks and labeled as theoretical. They do not constitute weaponized exploit code -- they are examples sufficient for developers to understand the attack surface and implement defenses. Disclosure risk is appropriate for the intended audience (PROJ-021 security review team). No attack surface in the report itself that would compromise the Jerry framework is identified. The report does not execute any finding against live systems.

---

## Gaps Identified (REVISE Required)

The following gaps must be addressed before re-scoring:

### GAP-1 (Internal Consistency -- Priority HIGH for GATE-5b): CVSS AV Field Error in RED-001

**Finding:** RED-001 CVSS vector is `AV:N` (Network) but the stated attack requires an authenticated internal user who authors a UC artifact within the Jerry framework. Per CVSS 3.1, `AV:N` requires the attack to be exploitable from the network without local access. An insider-only attack fits `AV:L` (Local) or `AV:P` (Physical).

**Required action:** Revise RED-001 CVSS vector from `AV:N/AC:H/PR:L/UI:R/S:C/C:L/I:H/A:N = 7.1` to `AV:L/AC:H/PR:L/UI:R/S:C/C:L/I:H/A:N = approximately 6.2`. If the analyst intends to maintain HIGH severity despite the corrected CVSS score, add a qualitative justification statement in the AS-6 section explaining why the corrected CVSS score underestimates the risk for the Jerry framework threat model (e.g., insider threat is high likelihood in a developer tooling context).

### GAP-2 (Internal Consistency -- Priority HIGH for GATE-5b): RED-005/AS-5 Source Attribution Contradiction

**Finding:** AS-5 section explicitly states "No separate RED-* finding created" but the Findings Table lists RED-005 with source "AS-5/AS-8." This creates ambiguity about whether a template injection finding exists in the formal findings inventory and whether it has been dispositioned for GATE-5b.

**Required action:** Choose one resolution: (a) Change the Findings Table to attribute RED-005 as "AS-8" only (since the RED-005 content is path traversal + Bash escalation, not template injection), and add a note to AS-5 stating that SEC-CD-001 escalation to HIGH is documented in the Deduplication Matrix but is not a new RED-* finding; or (b) Create RED-009 for the AS-5 template injection escalation of SEC-CD-001, add it to the Findings Table with appropriate severity (HIGH per the AS-5 escalation note), and update the L0 count accordingly.

### GAP-3 (Internal Consistency -- Priority MEDIUM): Escalated Count Discrepancy

**Finding:** L0 severity table shows "Escalated = 1" but the Deduplication Matrix shows two entries with "Escalates" as overlap type (RED-004 and RED-005).

**Required action:** Correct the L0 "Escalated" count to 2, or correct the Deduplication Matrix to use "Extends" for RED-005 if it is not considered an escalation. Document which definition of "escalated" is being used (severity upgrade only, or also includes scope extension).

### GAP-4 (Completeness/Traceability -- Priority MEDIUM): Deduplication Count Verifiability

**Finding:** The claim "23 prior findings accounted for" cannot be independently verified from the Deduplication Matrix alone. The matrix's explicitly listed confirmed-as-accurately-scoped table shows 7 findings; the remaining 16 are implied through RED-* linkage.

**Required action:** Add a complete enumeration of all 23 prior findings to the Deduplication Matrix (or as an appendix table) with their explicit disposition: escalated, extended, or confirmed-as-accurately-scoped. This enables a GATE-5b reviewer to independently verify that no prior finding was missed.

### GAP-5 (Completeness -- Priority MEDIUM): AS-5 Template Injection Escalation Not in Findings Table

**Finding:** AS-5 analysis concludes that SEC-CD-001 should be escalated to HIGH based on multi-angle analysis ("instead, SEC-CD-001 is escalated to HIGH"). However, this escalation is not reflected in the Findings Table. The Findings Table shows SEC-CD-003 as the only prior finding confirmed as HIGH in the confirmed-as-scoped table, and SEC-CD-001 appears in the Deduplication Matrix only as part of RED-002's "Extends" entry. A GATE-5b reviewer using the Findings Table as the canonical inventory would not see the AS-5 template injection HIGH escalation.

**Required action:** Resolve with the same action as GAP-2, option (b): add a RED-009 finding for the AS-5 template injection escalation of SEC-CD-001 to HIGH, or add an explicit escalation note to the Findings Table showing SEC-CD-001 escalated to HIGH by AS-5 analysis.

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Internal Consistency | 0.78 | 0.90+ | Correct RED-001 CVSS AV:N to AV:L; add qualitative HIGH justification if needed (GAP-1) |
| 2 | Internal Consistency | 0.78 | 0.90+ | Resolve RED-005/AS-5 contradiction by correcting Findings Table source attribution or creating RED-009 (GAP-2) |
| 3 | Completeness | 0.88 | 0.93+ | Add complete enumeration of all 23 prior findings to Deduplication Matrix (GAP-4); resolve AS-5 escalation tracking gap (GAP-5) |
| 4 | Internal Consistency | 0.78 | 0.90+ | Correct L0 Escalated count from 1 to 2 or harmonize Deduplication Matrix terminology (GAP-3) |
| 5 | Traceability | 0.85 | 0.93+ | Resolve AS-5 traceability gap as part of GAP-2/GAP-5 resolution |

---

## Anti-Leniency Statement

Per leniency bias counteraction rules, the following checks were applied:

- [x] Each dimension scored independently before computing composite
- [x] Evidence documented for each score with specific line references
- [x] Uncertain scores resolved downward (Internal Consistency: considered 0.80, resolved to 0.78 given three confirmed contradictions; Traceability: considered 0.87, resolved to 0.85 given broken AS-5 trace)
- [x] CVSS AV field error treated as a substantive methodological concern, not an editorial issue, in a C4 security report
- [x] No dimension scored above 0.95 (Actionability is 0.93, the highest, with specific evidence)
- [x] The composite score of 0.868 reflects genuine gaps that a security reviewer would need to resolve; it is not artificially depressed

The report is genuinely strong -- it demonstrates real adversarial value and rigorous structure. The composite of 0.868 places it in the "strong work, clear targeted improvements needed" range (calibration anchor: 0.85 = strong work with minor refinements). The gap to 0.95 (C-008 threshold) represents approximately 0.082 points, achievable in a single revision pass addressing the five identified gaps, primarily the three Internal Consistency corrections which carry 0.20 weight.

---

## Session Context Protocol (Handoff Schema)

```yaml
verdict: REVISE
composite_score: 0.868
threshold: 0.95
weakest_dimension: internal_consistency
weakest_score: 0.78
critical_findings_count: 0
iteration: 1
improvement_recommendations:
  - "Correct RED-001 CVSS AV:N to AV:L; add qualitative HIGH justification (GAP-1)"
  - "Resolve RED-005/AS-5 source attribution contradiction in Findings Table (GAP-2)"
  - "Add complete enumeration of all 23 prior findings to Deduplication Matrix (GAP-4 + GAP-5)"
  - "Correct L0 Escalated count discrepancy -- 1 vs 2 (GAP-3)"
  - "Resolve AS-5 template injection escalation tracking gap in Findings Table (GAP-5)"
```

---

*Score Report Version: 1.0.0*
*Agent: adv-scorer*
*Constitutional Compliance: P-003 (no recursive subagents), P-020 (user authority respected), P-022 (all findings evidence-based)*
*SSOT: `.context/rules/quality-enforcement.md`*
*H-15 Self-Review: Completed -- each dimension verified against rubric criteria independently; weighted composite mathematically verified (0.88*0.20 + 0.78*0.20 + 0.88*0.20 + 0.90*0.15 + 0.93*0.15 + 0.85*0.10 = 0.176 + 0.156 + 0.176 + 0.135 + 0.140 + 0.085 = 0.868); verdict matches score range table (0.85-0.91 = REVISE)*
*Created: 2026-03-09*
